Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
CALL
Qiagen
QGEN
$8.96B
| $1.55M | ﹤0.01% |
+32,200
| New | +$1.4M |
|
3002
Pan American Silver
PAAS
$20.3B
| $1.54M | ﹤0.01% |
54,361
+14,733
| +37% | +$381K |
|
3003
CALL
CME Group
CME
$95.7B
| $1.54M | ﹤0.01% |
+5,600
| New | +$1.52M |
|
3004
Bit Digital
BTBT
$523M
| $1.54M | ﹤0.01% |
704,000
+463,844
| +193% | +$1.02M |
|
3005
Agilon Health
AGL
$1.52B
| $1.54M | ﹤0.01% |
26,807
+7,985
| +42% | +$640K |
|
3006
Zymeworks
ZYME
$1.79B
| $1.54M | ﹤0.01% |
122,820
+47,390
| +63% | +$565K |
|
3007
Ivanhoe Electric
IE
$1.66B
| $1.54M | ﹤0.01% |
169,712
+56,596
| +50% | +$393K |
|
3008
Heritage Insurance Holdings
HRTG
$988M
| $1.54M | ﹤0.01% |
61,605
+16,363
| +36% | +$349K |
|
3009
Northeast Bank
NBN
$1.16B
| $1.54M | ﹤0.01% |
17,261
+5,688
| +49% | +$485K |
|
3010
CALL
Cadiz
CDZI
$284M
| $1.53M | ﹤0.01% |
+513,300
| New | +$1.47M |
|
3011
PUT
Campbell Soup
CPB
$6.91B
| $1.53M | ﹤0.01% |
50,000
| – | – |
|
3012
iShare MSCI Eurozone ETF
EZU
$9.99B
| $1.53M | ﹤0.01% |
+25,761
| New | +$1.46M |
|
3013
Select Water Solutions
WTTR
$2.68B
| $1.53M | ﹤0.01% |
176,679
+17,069
| +11% | +$147K |
|
|
RDUS
3014
DELISTED
Radius Recycling
RDUS
| $1.53M | ﹤0.01% |
51,405
+9,213
| +22% | +$271K |
|
3015
MDU Resources
MDU
$4.33B
| $1.52M | ﹤0.01% |
91,307
-80,376
| -47% | -$1.35M |
|
3016
Iovance Biotherapeutics
IOVA
$2.91B
| $1.52M | ﹤0.01% |
884,340
+313,504
| +55% | +$780K |
|
3017
PubMatic
PUBM
$793M
| $1.52M | ﹤0.01% |
122,113
+19,521
| +19% | +$206K |
|
|
DHC
3018
Diversified Healthcare Trust
DHC
$2.04B
| $1.52M | ﹤0.01% |
423,857
+168,307
| +66% | +$486K |
|
3019
First Business Financial Services
FBIZ
$597M
| $1.51M | ﹤0.01% |
29,853
+4,282
| +17% | +$205K |
|
3020
Transcat
TRNS
$881M
| $1.51M | ﹤0.01% |
17,593
+5,515
| +46% | +$451K |
|
3021
PUT
Iridium Communications
IRDM
$5.29B
| $1.51M | ﹤0.01% |
50,000
| – | – |
|
|
ARIS
3022
DELISTED
Aris Water Solutions
ARIS
| $1.51M | ﹤0.01% |
63,722
+31,572
| +98% | +$779K |
|
3023
Eagle Bancorp
EGBN
$883M
| $1.5M | ﹤0.01% |
77,240
+21,324
| +38% | +$396K |
|
|
ATYR
3024
aTyr Pharma
ATYR
$54M
| $1.5M | ﹤0.01% |
296,586
+59,495
| +25% | +$234K |
|
3025
Oil-Dri
ODC
$1.29B
| $1.5M | ﹤0.01% |
25,458
+8,462
| +50% | +$411K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.